<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-GTQBQKTV</identifier><date>2018</date><creator>Časar, Zdenko</creator><creator>Ule, Mojca</creator><relation>documents/doc/G/URN_NBN_SI_doc-GTQBQKTV_001.pdf</relation><relation>documents/doc/G/URN_NBN_SI_doc-GTQBQKTV_001.txt</relation><format format_type="issue">3</format><format format_type="volume">69</format><format format_type="type">article</format><format format_type="extent">str. 175-187</format><identifier identifier_type="ISSN">0014-8229</identifier><identifier identifier_type="COBISSID_HOST">1411934</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-GTQBQKTV</identifier><language>slv</language><publisher>Slovensko farmacevtsko društvo</publisher><source>Farmacevtski vestnik</source><rights>InC</rights><subject language_type_id="slv">analiza</subject><subject language_type_id="slv">delež uporabe</subject><subject language_type_id="slv">nasprotni ion</subject><subject language_type_id="slv">sol</subject><subject language_type_id="slv">zdravilna učinkovina</subject><title>Analiza izbire soli zdravilnih učinkovin v zdravilih, registriranih v ZDA med leti 2007 in 2016</title><title>Analysis of the selection of active pharmaceutical ingredients' salts in medicinal products registered in the USA between 2007 and 2016</title></Record>